European Archives - Page 767 of 1390 - European Medical Journal

FDA unveils new guidance of real world evidence

The FDA has released new guidance on the use of real-world data and real-world evidence in drug development.

The driving seat of organisational change

GOLD reviews the pharma industry approach to organisational change, strategising tips to drive it from the top down or bottom up.

EMJ wins a Queen's Award for Enterprise

Our company, EMJ, is one of 225 organisations nationally to be recognised with a Queen’s Award for International Trade.

Percutaneous Nephrostomy Insertion Training: An Overview

Urinary tract obstruction is a common acute presentation to secondary care. Relief of upper urinary tract obstruction is usually performed in acute cases, or in chronic obstruction where treatment of the causative process is not immediately possible.

The Current Treatment Landscape in Head and Neck Cancer

This webinar will explore the current evidence and management of head and neck cancer especially focusing on older adults. The speaker…

Routine vaccinations: road to recovery

The pharmaceutical industry needs to help restoring pre-pandemic routine vaccination levels and protect populations worldwide.

2022 pharma predictions – where are we now?

In this episode, at the season’s half way point, Marc, Helena and Isabel look back at our 2022 predictions for pharma industry – were our guests right?

Silent Myocardial Infarction in Hypereosinophilic Syndrome Overlapped with JAK2-Mediated Essential Thrombocytosis

JAK2-mediated thrombosis overlapping with silent myocardial infarction and an elevated eosinophil count associated with neuropathy…

Zika Virus Infection and Pathogenesis

Zika virus is associated with central nervous system involvement and a congenital syndrome following Zika infection in pregnancy…

Spring 2022 Highlights

In this one-off special, we look back at some of the most memorable moments from the 2022 series of the EMG Health Podcast.